Lazarex Cancer Foundation

Lazarex care program: this program focuses on improving the outcome of Cancer care for advanced stage Cancer patients, and the medically underserved, by identifying fda clinical trial options, providing assistance with out-of-pocket travel expenses for clinical trial participation and a travel companion if needed, and by facilitating community outreach and engagement. In 2021 we assisted 802 patients with this program despite covid-19, an increase of 11% over 2020. We continue to increase racial and ethnic diversity of participants in this program, achieving 37% with the national average in Cancer clinical trials at about 5%. 33% of patients assisted came from households earning less than $25,000 annually.

Lazarex Cancer wellness hub program (re-brand of community impact from 2020): Lazarex Cancer wellness hubs operated in philadelphia through drexel university and penn abramson, in los angeles through usc norris, and is rolling out in the san francisco east bay area in collaboration with john muir health. The goal of the Lazarex Cancer wellness hub program is to generate a replicable program that is place based, culturally appropriate, and community driven, that operates in at-risk communities of color across the continuum of Cancer care to improve Cancer health disparities and improve Cancer health outcomes.

Lazarex impact program: the goal of impact is to generate a sustainable proof of concept action plan to transform the status quo of clinical trial recruitment, enrollment, retention, minority participation, completion, and translational science, getting drugs to market faster, finishing trials on time and on budget, and most importantly providing equitable and timely access to Cancer discovery for all patients. In 2021, impact was in operation at penn abramson and md anderson comprehensive Cancer centers. In 2021 we served 339 patients in this program, with 31% minority participation, and 20% from households earning less than $25,000 annually.